APA (7th ed.) Citation

Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., . . . Tardif, J. (2015). Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. The New England journal of medicine, 373(23), 2247-2257. https://doi.org/10.1056/NEJMoa1509225

Chicago Style (17th ed.) Citation

Pfeffer, Marc A., et al. "Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome." The New England Journal of Medicine 373, no. 23 (2015): 2247-2257. https://doi.org/10.1056/NEJMoa1509225.

MLA (9th ed.) Citation

Pfeffer, Marc A., et al. "Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome." The New England Journal of Medicine, vol. 373, no. 23, 2015, pp. 2247-2257, https://doi.org/10.1056/NEJMoa1509225.